From the Sector

ITMA ASIA + CITME, Asia’s leading trade fair for textile machinery, took place in Shanghai with a considerable presence of VDMA member companies. The round about 40 exhibiting VDMA members covered nearly all different machinery chapters with a focus on spinning and manmade fibers, nonwovens, weaving, braiding, knitting & hosiery, finishing & dyeing and textile processing. They were part of a strong German presence with a total of around 60 German exhibitors – including non-machine manufacturers.

During a press conference on the first day of the show, Dr. Janpeter Horn, chairman of the VDMA Textile Machinery Association and managing director of August Herzog Maschinenfabrik expressed: “After years of cancelled or postponed trade fairs and travel restrictions, this year’s ITMA ASIA + CITME is the first edition of the show that can be attended not just by Chinese but by visitors from various countries and regions. The event is a good opportunity to meet customers and partners again in person and not just on a screen. ITMA ASIA + CITME provides a good chance to deepen the already good relations with China and other Asian countries further and to set-up new partnerships.”

Dr. Horn continued to present latest facts and figures about the German textile machinery industry. Between January and August 2023, the overall exports of textile machinery and accessories summed up to 1.7 billion euros, which was a slight decrease compared to the same period in 2022. The shipping to almost all major markets decreased between January and August: China: 440 million € (2022: 453 million €), Turkey: 205 million € (2022: 265 million €), USA: 177 million € (2022: 144 million €), India: 170 million € (2022: 228 million €).

Numerous VDMA member companies have production sites in the major Asian markets China and India and serve their customers in these countries from there. A latest VDMA business climate survey among the textile machinery companies in China showed, that 75% of all participants assessed their current business situation as either good (6%) or satisfactory (69%). For the coming quarter, 50% of the companies see the market to decline. Asked about the business situation during the next six months, 44% of the companies expect the market to remain stable, 56% expect the situation to become worse. This is also reflected in the HR of the companies: 63% expect the number of employees to remain unchanged.

The data and the information reported examine the performance relative to the companies Marchi & Fildi S.p.A. and Filidea S.r.l. during the year 1st January 2022 to 31st December 2022. In addition, with the aim of putting the data into a context of developments, a comparison with data pertaining to 2021 was also made.

Amongst the numerous data and insights provided by the analyses given in the Report, some relevant performance factors relating to environmental achievements emerge.

With reference to Marchi & Fildi, and in comparison to 2021, the year 2022 demonstrated:

• A unit reduction in water consumption of 57% and unit reduction of waste water of 19%
• A unit reduction in electric power consumption of 13%

An overall reduction in CO2 emissions (Scope I + Scope II) of 22% In the same period, for Filidea the following results are shown:

• A unit reduction in water consumption of 26%, unit waste water of 22%
• A reduction in unit natural gas consumption of 7%
• A reduction in unit electric power consumption of 14%
• An overall reduction in CO2 emissions (Scope I + Scope II) of 7%

These data offer quantitative feedback on the constant commitment to the optimisation of resources and use of production technologies with low energy impact, which the Group has adopted for years.

Massimo Marchi, Marchi & Fildi’s President, has this to say about the choice to invest in this form of reporting:
“The decision to write a Sustainability Report represents for us one of the elements which guide us towards the constant improvement of company performance with reference to ESG. This is one of the stages towards the formalisation of a strategic plan for the management of sustainability, a journey which the Group has been committed to for years and in which we believe 100%.”

EU-wide enforcement project found about 60 active substances in biocidal products that are not allowed on the EU, EEA and Swiss markets. One in three of the checked products did not comply with at least one of the checked legal requirements.
Helsinki, 21 November 2023 – The national enforcement authorities in 29 countries checked over 3 500 biocidal products. Overall, 37 % of the checked biocides were non-compliant with at least one of the checked legal requirements.
 
18 % of checked products were non-compliant with fundamental requirements that affect their safe use. Most of them either lacked a product authorisation or included non-allowed active substances. Most biocides with such major non-compliance were disinfectants, insecticides, and repellents/attractants. Inspectors found about 60 active substances that are not allowed in these products. All products that lacked authorisation or contained non-allowed active substances were withdrawn from the market. In some cases, criminal complaints or fines were issued.

The remaining 19 % non-compliant products were found to have minor deficiencies that did not affect safe use such as missing contact information of the supplier. In these cases the national enforcement authorities gave advice or administrative orders.

Much non-compliance was found in disinfectants sold to consumers. 265 disinfectants out of nearly 1 900 that were checked (14 %) were found to be non-compliant. This included serious compliance deficiencies such as lacking authorisation or incorrect labelling that usually led to the withdrawal of the disinfectants from the market.
 
The inspectors focused on disinfectants because new manufacturers entered the market with biocidal products at the early stages of the COVID-19 pandemic. Many of those disinfectants were not fully compliant with the EU’s Biocidal Products Regulation (BPR) and the related national transitional requirements for biocides.

• Revenue of US$3.9B, a decline of 1% QoQ and 20% YoY
• EBITDA of US$324M, an increase of 1% QoQ and a decrease of 37% YoY
• Operating cash flows of US$410M
• Net Operating Debt to Equity of 0.97x
• EPS of THB 0.00

Indorama Ventures Public Company Limited (IVL) reported stable third-quarter earnings as the company’s management focuses on conserving cash and improving competitiveness to bolster performance in a continued period of weakness in the global chemical industry.

Indorama Ventures achieved EBITDA of $324 million in 3Q23, an increase of 1% QoQ and a decline of 37% YoY, impacted by a weak economic environment, geopolitical tensions, and continued post-pandemic disruptions in global markets. Sales volumes dropped 5% from a year ago to 3.6 million tons as China recovers from the pandemic more slowly than expected and an extended period of destocking in the manufacturing and chemical sectors continues to normalize from unprecedented levels last year.

Management continues to focus on conserving cash, realizing efficiency improvements, and optimizing the company’s operational footprint to boost profitability. These efforts resulted in positive operating cash flow of US$410 million in the quarter, positive free cash flow of $79 million year to date, and room for further reductions in working capital going forward. The company’s AA- rating was maintained by TRIS in the quarter, with a stable outlook. 

The company expects the operating environment to improve in 2024 as customer destocking continues to ease across all three of Indorama Ventures’ segments. The ramp up of PET and fibers expansion projects operations in India and the U.S. will also contribute to increased volumes.  

Combined PET posted EBITDA of $146 million, a 25% decline QoQ, amid historically low benchmark PET margins, increased feedstock prices in Western markets, and lingering effects of destocking. Integrated Oxides and Derivatives (IOD) segment posted a 27% rise in EBITDA to $119 million QoQ, supported by strong MTBE margins in the Integrated Intermediates business. The Integrated Downstream portfolio’s profitability was impacted by destocking, inflationary pressures, and margin pressure from imports. Fibers segment achieved a 140% increase in EBITDA to $48 million QoQ as Lifestyle volumes grew in key markets in Asia, and the Mobility and Hygiene verticals benefited from management’s focus on optimizing operations and refocusing the organization. 
 

The European Chemicals Agency (ECHA) has published a new report on ‘Key areas of regulatory challenge 2023’ that identifies areas where research is needed to protect people and the environment from hazardous chemicals. It also highlights where new methods, that support the shift away from animal testing, are needed.

To further improve chemical safety in the EU, scientific research needs to deliver data that is relevant to regulating chemicals. In order to enhance the regulatory relevance of scientific data, ECHA has identified the following areas as priorities for research:

• Hazard identification for critical biological effects that currently lack specific and sensitive test methods: i.e. developmental and adult neurotoxicity, immunotoxicity and endocrine disruption
• Chemical pollution in the natural environment (bioaccumulation, impact on biodiversity, exposure assessment)
• Shift away from animal testing (read across under REACH, move away from fish testing, mechanistic support to toxicology studies e.g. carcinogenicity)
• New information on chemicals (polymers, nanomaterials, analytical methods in support of enforcement)

Background
The European Partnership for the Assessment of Risks from Chemicals (PARC), is a seven-year EU-wide research and innovation programme under Horizon Europe which aims to advance research, share knowledge and improve skills in chemical risk assessment.

ECHA’s role in PARC is to make sure that the funded scientific research addresses current challenges related to chemical risk assessment and adds value to the EU’s regulatory processes.

The key areas of regulatory challenge report can be seen as an evolving research and development agenda aiming to support and inspire the Partnership for the Assessment of Risks from Chemicals (PARC) and the wider research community. The list of research needs is not exhaustive. The next update to the report is expected in spring 2024.

Developments:

• Currency-neutral revenues up 1% driven by growth in all regions except North America
• Top-line development reflects focus on conservative sell-in and full-price business
• Gross margin up 0.2pp to 49.3% driven by reduced freight costs, a more favorable business mix, and lower inventory allowances; discounting levels continue to improve  
• Operating profit of € 409 million includes extraordinary expenses of around € 110 million
• Conservative sell-in strategy paying off as inventory position improves substantially versus Q2 level to € 4.8 billion; now down 23% year-over-year

Outlook
adidas expects revenues to decline at a low-single-digit rate
On October 17, adidas had adjusted its full year financial guidance to reflect both the positive impact of the second drop of some of its Yeezy inventory and the better-than-expected development of the underlying business. At the same time, macroeconomic challenges and geopolitical tensions persist. Elevated recession risks in North America and Europe as well as uncertainty around the recovery in Greater China continue to exist. In addition, the company’s revenue development will continue to be impacted by the initiatives to significantly reduce high inventory levels in North America and the company’s focus on full-price sales across its own channels. As a result, adidas now expects currency-neutral revenues to decline at a low-single-digit rate in 2023 (previously: decline at a mid-single-digit rate).

Underlying operating profit anticipated to reach a level of around € 100 million
The company’s underlying operating profit – excluding any one-offs related to Yeezy and the ongoing strategic review – is now anticipated to reach a level of around € 100 million in 2023 (previously: around break-even level). Including the positive impact from the two Yeezy drops in Q2 and Q3 of around € 300 million (previously: € 150 million), the potential write-off of the remaining Yeezy inventory of now around € 300 million (previously: € 400 million) and one-off costs related to the strategic review of up to € 200 million (unchanged), adidas now expects a reported operating loss of around € 100 million in 2023 (previously: loss of € 450 million).

Mahlo GmbH + Co. KG will present its systems and solutions for efficient and high-quality textile production and finishing together with Shanghai Kuantex at ITMA Asia (November 19 and 23). The focus will be on the machine manufacturer's new straightening concept, the Orthopac RXVMC.

"In the new straightening concept, special attention was paid to the straightening mechanics and their interaction with the analysis electronics of the probe system," explains Sales Manager Thomas Höpfl. The control concept is also new. A probe group at the leveler infeed detects distortions even before they reach the correction rolls. In this way, the rolls are brought directly into position and the fabric is corrected from the very first centimeter. A scanner group at the outfeed also detects possible residual distortion, which is corrected at the second straightening module. This enables an even more precise and faster response when it comes to reacting to rapidly changing distortions. The Orthopac RXVMC therefore shows its full strength when straightening knitwear and fabrics sensitive to distortion.

Also contributing to high-quality textile production and finishing is the Famacont PMC for controlling weft and stitch course density, which will also be on show at ITMA Asia. The Famacont PMC-15 uses a sensor to measure the yarn or stitch density and compares it with the target value stored in the recipe data management system. The detected deviation of the yarn density from the target value is used to fully automatically regulate the leading during the needling process on the stenter frame. Interested parties can have the mode of operation explained to them at the Mahlo booth with the help of a demo tower and their own or provided fabric samples.

Another major topic remains Industry 4.0, because the best measured data is of no use if it cannot be utilized. Mahlo has continuously developed its digital environment mSmart. "Our systems generate data that the customer can use immediately to regulate goods on-line. At the same time, all measured values are backed up in our data management system mLog enhanced and can be retrieved at any time. With this historical data, processes can be optimized and weak points in the process can be minimized," explains Sales Manager Thomas Höpfl.

Responsible innovation plays a leading role at GenovaJeans, the initiative dedicated to new-generation jeans GenovaJeans, the initiative held in Genoa from 5 to 8 October and dedicated to the new generation of jeans, set the premises for the creation of a community dedicated to this iconic, revolutionary and innovative garment.

30 prominent industry leaders, divided into three categories (heritage, new creatives and production chain) created a inspiring experience in historic venues in the heart of the city. Presented in-group exhibitions, they forged a circular journey from the design to the creation of jeans, from the ingredient to the final outfit, and vice versa.

Heritage brands, exploring the history, evolution and best practices of this iconic garment, were hosted inside the Biblioteca Universitaria and included Blue Blanket Division, Blue Of A Kind, Diesel, IMIJT35020 By Canova, Incotex Blue Division, Mud Jeans, Pepe Jeans, Roy Roger's, Stefano Chiassai and Tela Genova.

The new creatives, a new generation of designers who have adopted innovative eco-design strategies to create smart jeans, were present inside Edificio Metelino in the Darsena area and included Andrea Grossi, Gilberto Calzolari, Gimmijeans, Jeanne Friot, Marcello Pipitone with Albiate 1830, Ksenia Schnaider, Patine, Regenesi, The Blue Suit with ROICA™ by Asahi Kasei and Zerobarracento.

The production chain, composed of companies in the supply and value chain, representing the major stages in the production process, were made up of Albiate 1830 - Albini Group, Cadica, Candiani Denim, Circulose®, Officina39, Pure Denim with Bemberg™ By Asahi Kasei, Soko, Tencel™, Tonello, YKK Italia and were housed inside the Ex Oratorio di San Tommaso.

The responsible innovation, ethics and transparency adopted by each company taking part in the circular journey of GenovaJeans were explained through a QR code powered by C.L.A.S.S. (Creativity Lifestyle And Sustainable Synergy) that provided information on the garments, their composition, production phases and company values.

Highlights

• Net sales in the third quarter of 2023 were down by -20.3% organically versus a record Q3 2022 as expected due to -15% lower volumes (€-512 million) in a weaker macro environment and -5% lower prices (€-188 million) in a context of lower raw material costs and energy prices. On a sequential basis, net sales were down -11% versus Q2. The volume reduction was broad based across regions and businesses.
• Structural cost savings for the first nine months of 2023 amounted to €63 million, bringing the total savings since 2019 to €530 million.
• Underlying EBITDA of €702 million in Q3 2023 was down by -18.5% organically compared to a record Q3 2022 driven by lower volumes, partly offset by €36 million in positive net pricing and €41 million in lower fixed costs. Nine months EBITDA at €2,331 million is only down -1% organically versus 2022, a clear indication that strong historic pricing and cost discipline momentum is being maintained.
• The underlying EBITDA margin of 25.6% in Q3 2023 was sustained relative to Q3 2022 despite lower volumes, while nine months EBITDA margin of 25.9% is +1.3pp higher, mainly as a result of positive net pricing and cost discipline.
• Underlying Net Profit was €340 million in Q3 2023 compared to €509 million in Q3 2022.
• Free Cash Flow of €346 million in Q3 2023 resulted in a nine-month 2023 total of €1,027 million and a FCF conversion ratio of 39.4%.
• ROCE was 15.2%, broadly in line with Q3 2022.
• Continued strengthening of the balance sheet with underlying net debt at €2.8 billion, which translated to a historic low leverage of 0.9x.
• As explained on page 2, an interim dividend of €1.62 gross per share has been validated by the Board of Directors, in line with historical interim dividend policy to be paid by Solvay SA on January 17, 2024.

2023 Outlook
Given the current volume momentum, Solvay reconfirm their full year guidance, at the lower end of the prior EBITDA guidance range.

Solvay announced the future Board of Directors of SYENSQO, effective upon completion of the planned separation of Solvay into two companies – SOLVAY and SYENSQO – which is on track to be completed in December 2023.

SYENSQO’s Board will be composed of 10 members, including 6 independent members, 3 members representing the reference shareholder, Solvac, and the company CEO. They have deep expertise in specialty industries, international business operations, risk management, corporate governance, finance and clean technology.

The following individuals will serve on the SYENSQO Board of Directors:
Rosemary Thorne will serve as independent Director and Chair of the SYENSQO Board, as well as Chair of the Board’s Finance Committee. She is currently an Independent Director on the Solvay Board of Directors, appointed in 2014, and Chair of the Board’s Audit Committee. She is also an Independent Director on the Board of Merrill Lynch International (UK), a wholly-owned subsidiary of Bank of America, serving as Chair of the Audit Committee. Ms. Thorne has decades of financial leadership experience across a wide range of industries. She previously served as Chief Financial Officer at J. Sainsbury, the UK’s largest supermarket chain at the time; Bradford & Bingley; and Ladbrokes. Ms. Thorne previously sat as an Independent Director on the Boards of Royal Mail Group, Cadbury Schweppes, Santander UK, First Global Trust Bank and Smurfit Kappa Group.

Dr. Ilham Kadri will serve as Chief Executive Officer and member of the Board of Directors of SYENSQO. She is currently CEO and President of the Executive Committee at Solvay. Ms. Kadri has successfully led the turnaround of Solvay, delivering double-digit EBITDA growth and 18 consecutive quarters of positive free cash flow, deleveraging the balance sheet and promoting superior people engagement. She is an independent Board member at A.O. Smith and L’Oréal. She is active in non-profit organizations, as Chair of the World Business Council for Sustainable Development (WBCSD), member of the steering committee of the European Round Table of Industrialists (ERT) as well as a permanent member of the World Economic Forum’s International Business Council (WEF). Ms. Kadri has extensive leadership experience across a variety of industries in four continents and with leading industrial multinationals, including Shell, UCB, Huntsman, Dow, Sealed Air. Prior to Solvay, she was CEO and President of Diversey in the USA, led the company’s return to profitability and resulting spin off and divestiture to Bain Capital. She founded two non-Profit foundations: the Solvay Solidarity Fund in Belgium in 2020 which supported more than 7000 families affected by Covid-19 and natural disasters; and founded the ISSA Hygieia Network in 2015 in the USA, to help women in the cleaning industry. She received two Doctor Honoris Clausa from EWHA University in Korea and Université de Namur in Belgium.

Julian Waldron will serve as independent Director and Chair of the Audit Committee. He currently serves as Deputy Executive Chairman of privately-held Albea Group, a global beauty and personal care packaging company which operates 35 facilities in Europe, Asia and the Americas. Mr. Waldron has held senior leadership roles at several leading listed companies in the industrial, technology and services sectors and brings a wealth of expertise in finance and business operations. Prior to joining Albea in 2022, he was Chief Financial Officer of Suez for three years after serving as Chief Financial Officer and subsequently Chief Operating Officer of Technip. He started his career at UBS Warburg where he spent 14 years. Mr. Waldron also served as an independent Board member and Chairman of finance, risk and investments at Carbon Clean, a privately-owned carbon capture company dedicated to achieving net zero.

Heike Van de Kerkhof will serve as independent Director and Chair of the Nomination Committee. She currently sits on the Board of OCI N.V.. Ms. Van de Kerkhof brings more than 30 years of experience in the chemicals, oil & gas and materials industries, having served in numerous leadership roles around the globe. From 2020 to 2023, she was Chief Executive Officer of Archroma Management, a global specialty chemicals company. During her tenure, she successfully completed the transformational acquisition of Huntsman’s Textile Effects business. Prior to her role at Archroma, Ms. Van de Kerkhof served as Vice President of Lubricants, Western Hemisphere at BP, and held positions at Castrol, The Chemours Company, and Neste Corporation. She also held many leading roles within DuPont over 18 years.

Matti Lievonen will serve as independent Director and Chair of the Compensation Committee. He is currently an independent director on the Solvay Board, appointed in 2017. Mr. Lievonen is a proven executive in the energy, forestry, power and automation industries with an extensive track record of leading businesses through climate transition. For over ten years until 2018, he served as Chairman and Chief Executive Officer of Neste Corporation, a global leader in next-generation renewable fuels and chemicals. During his time at Neste, Mr. Lievonen successfully promoted the development of clean fuels as well as Finland’s bioeconomy strategy in advancing renewable transportation fuels. He has also been involved with organizations such as Fortum Board, SSAB, Nynäs AB, Ilmarinen, and the HE Finnish Fair Foundation. Until 2021, Mr. Lievonen was also Chairman of the Board of Directors at Fortum. He has been recognized for his admirable leadership and expertise, and in 2016 was awarded an Honorary Doctorate of Technology by the Aalto University Schools of Technology.

Dr. Françoise de Viron will serve as non-independent Director, Chair of the ESG Committee and Vice-Chair of the Board. She is currently a director of the Solvay Board, appointed in 2013. Ms. de Viron is a regarded academic leader and has extensive experience in innovation, R&D and qualitative research. She is a Professor Emeritus at the Faculty of Psychology and Education Sciences and Louvain School of Management at UCLouvain in Belgium where she has been an Academic Member of various groups at UCLouvain. Ms. de Viron previously served as the president of AISBL EUCEN – the European Universities Continuing Education Network. Prior to her university position, from 1985 to 2000, she was in charge of developing Artificial Intelligence applications at Tractebel S.A. (now Tractebel-Engie).

Roeland Baan will serve as independent Director. He currently serves as President and Chief Executive Officer of Topsoe, a privately-held leading provider of clean energy and petrochemical technologies. He is also Chairman of the Supervisory Board of SBM Offshore NV. Roeland Baan has extensive experience in supply chain management, M&A, business development and operations management. Prior to joining Topsoe in 2020, he was President and CEO of Outokumpu and has held several executive roles at global organizations such as Aleris International, ArcelorMittal and SHV NV. He spent over 16 years in various roles across the globe at Shell, living in South America, in Africa and in the United Kingdom.

Edouard Janssen will serve as non-independent Director. He is currently a Director on the Solvay Board, appointed in 2021. Earlier this year, he was appointed Chief Financial Officer of D’Ieteren Group, a European leader in automotive distribution services. Mr. Janssen is also a Board member of privately-held Financière de Tubize and Union Financière Boël, as well as Co-Founder and Chair of Trusted Family. Mr. Janssen is active in academics, as Vice-Chair of the International Advisory Board of the Solvay Brussels School of Economics and Management and on the advisory board of the INSEAD HGIBS. He brings expertise in finance, strategy, entrepreneurship, business management, planning and marketing. He has served as Solvay’s Vice President in strategy and M&A between 2019 and 2021, and prior to that, he was the US-based General Manager for North- and Latin America at Solvay’s Aroma Performance Global Business Unit.
 
Dr. Mary Meaney will serve as non-independent Director. She is currently a member of the Board of Directors and of the Audit Committee of Groupe Bruxelles Lambert SA. She also sits on the Board of Directors and the Remuneration Committee of Beamery, the privately-held talent management company. She is a member of the Board of Directors and of the Finance Committee of Imperial College, London.Dr. Meaney will bring expertise in Strategy, M&A, and change management, which she acquired over a 24-year career at McKinsey. She was a Senior Partner, served on the McKinsey Shareholders Council and led McKinsey’s global Organization practice.

Nadine Leslie will serve as independent Director and is based in the United States of America. She is currently a member of the Board of Directors of Provident Financial Services , as well as a Non-Executive Director of Seven Seas Water Corporation, a water and wastewater treatment multinational company. She also sits on the Board of Trustees of Hackensack Meridian Health Network and is active as strategic consultant for civil engineering firm T&M Associates. Over a 22-year career at Suez, Ms. Leslie held several leadership positions, the last one being Chief Executive Officer of Suez North America, until 2022. Previously she served as Executive Vice President Health & Safety.